Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors
AssigneeThe Florida State University Research Foundation, Inc.
InventorsEric Holmes, Gary Ostrander
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Florida State University Research Foundation, Inc.
InventorsEric Holmes, Gary Ostrander
Estimating the term…
The present invention concerns the use of an alpha-glucosidase glycoprotein processing inhibitor for the treatment or prevention of human coronavirus infections, such as SARS-CoV-2 or SARS-CoV-2 variant infections. Aspects of the invention include methods for treating or preventing coronavirus infection, or a symptom thereof, by administering an alpha-glucosidase glycoprotein processing inhibitor, such as castanospermine, or a pharmaceutically acceptable salt, derivative, or prodrug thereof, to a human subject; methods for inhibiting human coronavirus infection in a human cell in vitro or in vivo; pharmaceutical compositions; packaged dosage formulations; and kits for treating or preventing human coronavirus infection.
A composition comprising (a) castanospermine or a prodrug thereof and (b) a sugar, a starch, or a combination thereof.
A composition for inhalation comprising castanospermine or a prodrug thereof and a carrier suitable for inhalation.
Dependencies are inferred from the claim text.